Breaking News
Get 50% Off 0
Unlock Premium Data: Up to 50% Off InvestingPro CLAIM SALE
Close

Eli Lilly and Company (LLY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Eli Lilly's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
883.88 -2.11    -0.24%
21/06 - Closed. Currency in USD ( Disclaimer )
After Hours
885.46
+1.58
+0.18%
19:59:42 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 3,437,145
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 879.80 - 891.97
Eli Lilly 883.88 -2.11 -0.24%

LLY Analyst Price Target

 
Our Eli Lilly and Company stock forecast data is based on consensus analyst prediction, covering public companies earnings per share and revenue. Assess the Eli Lilly stock price estimates. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst 12-Month LLY price targets.

Overall Consensus

Buy Sell Neutral

Outperform

Analysts 12-Month Price Target

Average 855.39 (-3.22% Downside)

High | 1,023.00

Average | 855.39

Low | 540.00

Past 12 Months

12-Month Forecast

Data Based on a Poll of 31 Analysts

Technical Analysis

Summary:Neutral
Moving Averages:BuyBuy (7)Sell (5)
Technical Indicators:SellBuy (2)Sell (4)

Recent Sentiments

BearishBullish
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

LLY Comments

Write your thoughts about Eli Lilly and Company
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
damian ddd
dam_79 Jun 18, 2024 1:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
dump this scam while you can
Vlas Dacian
Vlas Dacian Jun 10, 2024 3:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What a bubble ! Start building short stake … first entry 870$ , next 890$
ST Park
ST Park Jun 10, 2024 3:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Maria Kenny
Maria Kenny May 23, 2024 11:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
me two drugs popping up. good decision.
Mike Morey
Mike Morey Feb 24, 2024 11:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
so happy the I hold this stock. and have for sometime now. LETS GOOOO
damian ddd
dam_79 Feb 24, 2024 11:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
comment so gay
Kevin Paulik
Kevin Paulik Feb 24, 2024 11:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
damian ddd with a name like MUDLOG you would know!
Eddie Keegan
Eddie Keegan Feb 21, 2024 9:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this is a hugeeeeee mover outside of the AI frenzy that hardly gets attention.
Shah King
Shah King Feb 20, 2024 7:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how come no one is commenting on it ? until a strong competitor comes or major frequent adverse effects gets reported, this ain't goin down
D Petersen
D Petersen Feb 16, 2024 5:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Near $900 will be the time to load up on 3 to 6 month puts.
damian ddd
dam_79 Feb 16, 2024 4:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
stupid bubble, childish
Colter Bauman
Colter Bauman Feb 16, 2024 4:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
mate, it isn't gonna pop, at least until some competitor comes
Mel Straub
Mel Straub Feb 16, 2024 3:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
So basically when you first start taking the drug you will probably get very sick and not be able to eat but as starvation kicks in you will find that some foods don't make you sick once you know what you can eat more than likely the weight loss will stop. Good luck to anyone trying the drug.
Mel Straub
Mel Straub Feb 16, 2024 3:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The shot only works for about 3 months after that you will figure out what foods you can eat and not get sick
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email